The enlargement of medical and leisure marijuana legalization facilitates affected person entry to cannabis, and plenty of sufferers with epilepsy pursue marijuana as a therapy for seizures. We administered a nine-item survey on marijuana use to sufferers seen in an epilepsy clinic over a 9 month interval at a tertiary care middle in Oregon the place leisure use was legalized in 2015. The vast majority of respondents (n = 39) reported cannabis use for the aim of treating epilepsy (87.2%, n = 34), and strongly agreed (53.8%, n = 21) or agreed (28.2%, n = 11) that cannabis use improved seizure management. Probably the most generally chosen cannabis strains have been excessive cannabidiol ( CBD) (30.8%, n = 12) or a number of varieties (30.8%, n = 12), with administration strategies of smoking (66.7%, n = 26), edibles (48.7%, n = 19), and concentrates (43.6%, n = 17). Extra contributors reported utilizing marijuana with primarily CBD than primarily tetrahydrocannabinol (THC) or equal CBD:THC content material, and only a few girls reported utilizing marijuana with primarily THC in contrast with males (10% of feminine versus 47% of male respondents). Solely 2 of 39 contributors have been in a position to give an actual dosage utilized in milligrams. Medical and leisure dispensaries have been the commonest cannabis sources, adopted by homegrown and pals/relations. Though pharmaceutical CBD extract is now Meals and Drug Administration (FDA)-approved for sure epilepsy varieties, entry stays restricted. Additional analysis is required to grasp leisure cannabis use amongst sufferers with epilepsy whereas scientific analysis for pharmaceutical cannabis merchandise continues.
Printed by Elsevier Inc.